Valeant shares sink again despite new denials in Philidor crisis

Valeant Pharmaceuticals laid out a comprehensive refutation of the fraud allegations that have been raised against it by a short-seller, but the denials failed to halt the slide in the company's shares on Monday.

from CBC | Health News http://ift.tt/1XtnPwW